Dopaminergic neuron (midbrain type, substantia nigra)

"Dopamine neuron replacement" refers to therapeutic approaches aimed at restoring the function of dopamine-producing (dopaminergic) neurons, typically through cell transplantation or stem cell-driven regeneration, in patients with loss of these cells, as seen in Parkinson's disease. The strategy involves introducing new dopaminergic neurons—derived from sources like human embryonic stem cells, fetal midbrain tissue, or induced pluripotent stem cells—into brain regions such as the striatum or substantia nigra, to re-establish dopaminergic signaling disrupted by disease. This is not a druggable molecular target by itself, but rather a cell-based strategy targeting disease pathology at the neuronal population level. Main challenges include cell survival, functional integration, immune rejection, and risk of overgrowth or tumorigenesis[1][2][5][6][7][8].

Other names

Dopaminergic neuronmidbrain dopamine neuronmDA neuronsubstantia nigra dopaminergic neuronDA neuron

Dopamine precursor supplementation, Dopamine receptor agonism, Enzyme inhibition (dopamine breakdown), Cell replacement to restore dopaminergic signaling[1][4][5][6][8]